Literature DB >> 3684504

Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats.

J Lutz1, M Stark.   

Abstract

The decline of the concentration of perfluorochemicals (PFC) after a single injection of three different doses was studied in the circulation of rats. The doses used amounted to 4.4, 10 and 14 g/kg body weight of Fluosol-DA, an emulsion of 7 parts of perfluorodecalin (FDC) and 3 parts of perfluorotripropylamine (FTPA). This also allowed testing of the composition of the emulsion remaining in the circulation and of that found in the liver. After two days a decrease of the half life from 34.0 +/- 0.7 to 17.1 +/- 4.3 h was found within the circulation at the highest dose. At the same time a change in the composition of the emulsion in the blood stream occurred, favouring the fraction of FTPA. FTPA increased from 28.3 +/- 1.4 to 54.4 +/- 8.1% on the fourth day. Whereas in the cells of the liver PFC droplets may be broken up, freed from their surfactant layer and handled according to their individual components, for PFC in the blood stream an unchanged composition should be assumed. Both results, the decreasing half life and the change in composition of the circulating emulsion may best be explained by a shrinking and instability of the emulgator film, showing the necessity for development of a superior surfactant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3684504     DOI: 10.1007/bf00581913

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  14 in total

1.  Intralipid and reticuloendothelial clearance.

Authors:  G W Fischer; K W Hunter; S R Wilson
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

2.  High oxygen extraction combined with extensive oxygen consumption in the rat liver perfused with Fluosol-DA a new perfluoro compound emulsion.

Authors:  J Lutz; B Decke; M Bäuml; H G Schulze
Journal:  Pflugers Arch       Date:  1978-08-25       Impact factor: 3.657

3.  Studies on RES function in rats and mice after different doses of fluosol.

Authors:  J Lutz
Journal:  Prog Clin Biol Res       Date:  1983

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships.

Authors:  J G Riess
Journal:  Artif Organs       Date:  1984-02       Impact factor: 3.094

6.  Fluosol 43 intravascular persistence in mice measured by 19F nmr.

Authors:  M C Malet-Martino; D Betbeder; A Lattes; A Lopez; R Martino; G Francois; S Cros
Journal:  J Pharm Pharmacol       Date:  1984-08       Impact factor: 3.765

7.  Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

Authors:  G M Vercellotti; D E Hammerschmidt; P R Craddock; H S Jacob
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

8.  Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.

Authors:  O Castro; A E Nesbitt; D Lyles
Journal:  Am J Hematol       Date:  1984-01       Impact factor: 10.047

9.  Steroid secretion by rat testes perfused with perfluorochemicals as oxygen carriers.

Authors:  C Chubb; P Draper
Journal:  Am J Physiol       Date:  1985-04

10.  Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.

Authors:  T Mitsuno; H Ohyanagi; R Naito
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

View more
  1 in total

1.  Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR).

Authors:  L Zarif; M Postel; B Septe; L Trevino; J G Riess; A M Mahé; R Follana
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.